These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Notch 1 overexpression inhibits osteoblastogenesis by suppressing Wnt/beta-catenin but not bone morphogenetic protein signaling. Deregowski V; Gazzerro E; Priest L; Rydziel S; Canalis E J Biol Chem; 2006 Mar; 281(10):6203-10. PubMed ID: 16407293 [TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk. Tuli R; Tuli S; Nandi S; Huang X; Manner PA; Hozack WJ; Danielson KG; Hall DJ; Tuan RS J Biol Chem; 2003 Oct; 278(42):41227-36. PubMed ID: 12893825 [TBL] [Abstract][Full Text] [Related]
9. Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells. Staal FJ; Burgering BM; van de Wetering M; Clevers HC Int Immunol; 1999 Mar; 11(3):317-23. PubMed ID: 10221643 [TBL] [Abstract][Full Text] [Related]
11. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895 [TBL] [Abstract][Full Text] [Related]
12. The bone morphogenetic protein 2 signaling mediator Smad1 participates predominantly in osteogenic and not in chondrogenic differentiation in mesenchymal progenitors C3H10T1/2. Ju W; Hoffmann A; Verschueren K; Tylzanowski P; Kaps C; Gross G; Huylebroeck D J Bone Miner Res; 2000 Oct; 15(10):1889-99. PubMed ID: 11028440 [TBL] [Abstract][Full Text] [Related]
14. Chondrogenic differentiation of murine C3H10T1/2 multipotential mesenchymal cells: I. Stimulation by bone morphogenetic protein-2 in high-density micromass cultures. Denker AE; Haas AR; Nicoll SB; Tuan RS Differentiation; 1999 Jan; 64(2):67-76. PubMed ID: 10234804 [TBL] [Abstract][Full Text] [Related]
15. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. Ikeda S; Kishida S; Yamamoto H; Murai H; Koyama S; Kikuchi A EMBO J; 1998 Mar; 17(5):1371-84. PubMed ID: 9482734 [TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein-2 enhances Wnt/beta-catenin signaling-induced osteoprotegerin expression. Sato MM; Nakashima A; Nashimoto M; Yawaka Y; Tamura M Genes Cells; 2009 Feb; 14(2):141-53. PubMed ID: 19170762 [TBL] [Abstract][Full Text] [Related]
17. BMP-2-enhanced chondrogenesis involves p38 MAPK-mediated down-regulation of Wnt-7a pathway. Jin EJ; Lee SY; Choi YA; Jung JC; Bang OS; Kang SS Mol Cells; 2006 Dec; 22(3):353-9. PubMed ID: 17202865 [TBL] [Abstract][Full Text] [Related]
18. New steps in the Wnt/beta-catenin signal transduction pathway. Sakanaka C; Sun TQ; Williams LT Recent Prog Horm Res; 2000; 55():225-36. PubMed ID: 11036939 [TBL] [Abstract][Full Text] [Related]
19. Functional domains of axin. Importance of the C terminus as an oligomerization domain. Sakanaka C; Williams LT J Biol Chem; 1999 May; 274(20):14090-3. PubMed ID: 10318824 [TBL] [Abstract][Full Text] [Related]